XML 37 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1
Operating Segments (Tables)
 9 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Operating Results For The Company's Reportable Segments Operating results for the Company’s reportable segments for each period presented in the consolidated statements of income and comprehensive income were as follows.
Three Months Ended December 31,Nine Months Ended December 31,
(in thousands of dollars)2023202220232022
SALES AND OTHER OPERATING REVENUES
   Tobacco Operations$743,933 $724,589 $1,742,494 $1,642,682 
   Ingredients Operations77,574 70,450 235,219 233,163 
Consolidated sales and other operating revenues$821,507 $795,039 $1,977,713 $1,875,845 
OPERATING INCOME
   Tobacco Operations$87,605 $77,104 $148,875 $119,010 
   Ingredients Operations2,167 767 4,964 9,876 
Segment operating income89,772 77,871 153,839 128,886 
Deduct: Equity in pretax (earnings) loss of unconsolidated affiliates (1)
(1,384)(345)3,495 (208)
              Restructuring and impairment costs (2)
(924)— (3,523)— 
Consolidated operating income$87,464 $77,526 $153,811 $128,678 

(1)Equity in pretax earnings (loss) of unconsolidated affiliates is included in segment operating income (Tobacco Operations), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income.
(2)Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income. See Note 2 for additional information.